AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Pfizer Ltd. Regulatory Filings 2024

Apr 17, 2024

60507_rns_2024-04-17_3753b2ad-9171-4d8d-b5f4-6e01c47c8291.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

April 17, 2024

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Pfizer Limited - Non-Applicability of Annual Disclosure to be made by an entity

identified as a Large Corporate.

I, Prajeet Nair, Director – Corporate Services & Company Secretary of Pfizer Limited (“Company”) hereby confirm that, the Company has no borrowings as on March 31, 2024 and does not fall under the category of Large Corporate as per the SEBI circular dated November 26, 2018 bearing number SEBI/HO/DDHS/CIR/P/2018/144 and amendments thereof. Accordingly, the requirement for submission of Annual disclosure under the said Circular is not applicable to the Company.

Thanking you,